Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia.
Anti-inflammatory & anti-allergy agents in medicinal chemistry（2021）
摘要
We hope that this finding could inspire further studies on the efficacy and safety of the concomitant use of anti-IL-5 and TKI.
更多查看译文
关键词
Asthma,chronic myeloid leukemia (CML),eosinophilic count.,hypereosinophilia (HE),mepolizumab,tyrosine kinase inhibitors (TKI)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要